Achillion Pharma Stock Price (NASDAQ:ACHN)

Add to My Stocks
$4.13 $0.02 (0.48%) ACHN stock closing price May 23, 2017 (Closing)
Achillion Pharma
23 MAY 2017
amigobulls logo
ACHN hand_up
ACHN vs S&P 500
Closing Price: May 23, 2017
$4.13 ( -0.48%)
S&P 500
2398.4 ( 0.18%)
52 Week Price Range
1 Year Return: -51.12%
Q1 Growth*
Profitable ?
net image
2017 Q1 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Achillion Pharma Snapshot Video

12 5 2 1

ACHN Stock Details

Prev Close* : $4.15
Market Cap:
Day Low: $4.11
52 Week Low: $3.15
Open: $4.12
Volume: 693024
Day High: $4.23
52 Week High: $10.06

Latest Stock Market News

Latest Articles

Achillion Pharma News - From Partners

ACHN Stockcharts

View ACHN PE ratio, PS ratio stocks charts and compare with peers.
ACHN Chart
Note: Compare Achillion Pharma stock price history with the index and industry peers.

Achillion Pharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Achillion Pharma Financial Ratios

Receivables Turnover

ACHN Industry Peers

Company Price Change (%)
Anaptysbio Inc (ANAB)27.290.38 (1.41%)
Inovio Pharma (INO)7.130.04 (0.56%)
Gilead Sciences (GILD)64.690.33 (0.51%)
Johnson & Johnson (JNJ)127.520.26 (0.2%)
Merck (MRK)64.550.51 (0.8%)
Biocryst Pharma (BCRX)5.150.09 (1.72%)
Enanta Pharma (ENTA)31.50.37 (1.16%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Sangamo BioSciences (SGMO)8.20.75 (10.07%)
Puma Biotech (PBYI)57.85.2 (9.89%)
Compugen (CGEN)5.30.25 (4.95%)
Lion Biotech (LBIO)6.40.3 (4.92%)
Vital Therapies (VTL)3.20.15 (4.92%)
Uniquire (QURE)5.870.23 (4.08%)
Agenus (AGEN)3.530.13 (3.82%)
Top gainers from Medical-Biomed-Genetics industry
* As of May 24, 2017
CompanyPriceChange (%)
Alexion Pharma (ALXN)104.6410.78 (9.34%)
Sorrento Therapeutics (SRNE)1.5750.15 (8.7%)
MannKind (MNKD)1.30.07 (5.11%)
MiMedx (MDXG)13.620.71 (4.95%)
Fate Therapeutics (FATE)3.640.14 (3.7%)
Trevena (TRVN)2.880.1 (3.36%)
ALBIREO PHARMA (ALBO)21.210.66 (3.02%)
Top losers from Medical-Biomed-Genetics industry
* As of May 24, 2017

Achillion Pharmaceuticals, Inc. Stock News - Partner Headlines

Achillion Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues15M66.12M--2.6M
Net Income-61.7M-5.03M-69M-58.94M-47.12M
Total Operating Expense79.86M81.22M69.42M59.47M49.89M
view Achillion Pharmaceuticals, Inc. income statement
balance sheet20162015201420132012
Total Assets413.87M464.52M156.8M162.41M81.53M
Total Liabilities14.42M14.88M13.33M9.45M9.48M
Shareholders Equity399.45M449.63M143.46M152.95M72.04M
view Achillion Pharmaceuticals, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-16.33M0.32M4.71M0.01M-3.43M
Net Cash From (Used By) Operating Activities-65.65M5.57M-55.52M-53.63M-46.53M
Increase (Decrease) In Prop Plant And Equipment-2.5M-0.7M-0.94M-0.4M-0.65M
view Achillion Pharmaceuticals, Inc. cashflow statement

Achillion Pharma Stock Message Board

Mike-Zaman on Achillion Pharma stock analysis ($9.89)
Keep a close eye on Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN). Billionaire Steve Cohen's Point72 Asset Management disclosed in an SEC filing a 5% (5,879,244 shares) stake in the company

Read more at Mike Zaman website

An investor needs to spend 4.13 to buy ACHN stock, as the closing Achillion Pharma stock price is 4.13. The total market value as denoted by 567.4M for Achillion Pharma, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Achillion Pharma stock analysis.

For recognizing and analyzing the real performance of Achillion Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume of shares traded stood at 693024 on the last trading day, as is evident from Achillion Pharma stock chart, and ACHN stock quote data. To check the historical stock price movement, all time high, and all time low of ACHN, view Achillion Pharma stock price history.